Clinical Trials Browser

Withdrawn × talazoparib × Tumor-Agnostic × Clear all

NCT06762808 2025-08-15

Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC

Phase 2 Withdrawn

Carcinoma, Squamous Cell